← SynDRA
semaxanib
SynDRA canonical compound SYN0042808 — structure-anchored drug synonym record
| Primary target(s) | PDGFRB |
|---|
| Mechanism of action | VEGFR inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- VEGFR inhibitor
- FLT1 INHIBITOR
- KDR INHIBITOR
- KIT INHIBITOR
- PDGFRB INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ABL1
- NEK2
- PLK1
- PKN2
- PIM3
- PIM2
- PIM1
- PHKG2
- PDPK1
- PBK
- PAK4
- PAK1
- NTRK3
- NTRK2
- NTRK1
- NEK4
- MKNK2
- PLK4
- MINK1
- MET
- MELK
- MATK
- MARK3
- MARK2
- MAPKAPK5
- MAPKAPK3
- MAPKAPK2
- MAPK9
- MAPK8
- MAPK13
- MAPK12
- MAPK1
- PLK3
- PRKAA1
- MAP4K4
- RPS6KA3
- TYK2
- TSSK2
- TSSK1B
- TAOK1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- KC1A
- KC1D
- VGFR2
- VGFR1
- ST17A
- M4K5
- M4K4
- M4K2
- KSYK
- KS6B1
- KS6A3
- KPCD3
- KPCD2
- KCC2G
- KCC2D
- KCC2B
- KCC1A
- KC1G3
- KC1G2
- VGFR3
Drug classes
- Angiogenesis Inhibitors
- Protein Kinase Inhibitors
Cross-references
Synonyms
- Sugen 5416
- RefChem:931606
- Semaxinib
- 3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1H-indol-2-one
- 3-((3,5-dimethyl-1H-pyrrol-2-yl)methylene)indolin-2-one
- (E)-3-((3,5-Dimethyl-1H-pyrrol-2-yl)methylene)indolin-2-one
- emaxanib
- Kinome_2848
- Semaxanib(SU5416)
- SCHEMBL19572
- orb1306586
- SCHEMBL5559281
- SCHEMBL29373311
- WLZ5205
- WUWDLXZGHZSWQZ-UHFFFAOYSA-N
- GLXC-05949
- HMS3374P03
- HMS3651F17
- AKOS028108497
- SB16592
- DA-43377
- NCI60_034480
- F869515
- 3-[(2,4-Dimethylpyrrol-5-yl)methylene]-2-indolinone
- 3-[(2,4-Dimethylpyrrol-5-yl)methylidene]-indolin-2-one
- 1,3-Dihydro-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-2H-indol-2-one
- SU 5416
Look up semaxanib in the interactive SynDRA portal →